AllHome Valuation Doubles After ₹200 Crore Funding Round
🚀 PharmEasy Founders’ New Venture AllHome Raises ₹200 Cr, Valuation Doubles🚀
From Healthtech to Hometech: The founders of PharmEasy are making massive waves with their new venture! 💥
🏠 AllHome Raises ₹200 Crore in Series B!
The home improvement and interior design startup, founded by PharmEasy co-founders (Dharmil Sheth, Dhaval Shah, Hardik Dedhia, and Siddharth Shah), has just locked in fresh capital, and its growth is skyrocketing.
📊 The Key Highlights:
💰 The Cheque: ₹200 Crore (mix of equity and debt) led by tech-giant Bessemer Venture Partners, along with Stride Ventures and major family offices.
📈 Valuation Doubles: The company’s valuation has skyrocketed to ₹2,000 Crore—doubling in just 12 months!
🚀 Unreal Performance: Despite being just a year into operations, AllHome is already profitable at the EBITDA level (18-20% margins) with an annual revenue run rate of ₹400+ Crore.
🎯 What does AllHome do?
They operate a "house of brands" marketplace for premium architectural and interior design products (surfaces, hardware, bath fittings, lighting, and facades). They are organizing India’s massive, highly fragmented $50 Billion building materials sector.
🔮 What's Next?
The new funds will be used to heavily scale up their physical experience centers, expand manufacturing capabilities, and boost their tech stack. Their next milestone? Crossing ₹1,000 Crore in revenue over the next 4 to 6 quarters.